Christina Washington
OU Health Stephenson Cancer Center · Stephenson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christina Washington as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:58 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06494150 · Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)University of Oklahoma · active not recruiting · Low Grade Ovarian Serous Adenocarcinoma · principal investigator
- Ph2NCT05512208 · A Phase 2 Study of Avutometinib (VS-6766) Plus DefactinibUniversity of Oklahoma · recruiting · Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer · principal investigator
- Ph1NCT03932409 · Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial CancerUniversity of Oklahoma · active not recruiting · Endometrial Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:58 UTC. The ranking covers the 200 most relevant of 29 PubMed records, and a shared surname and initials can bring in a namesake. All 29 on PubMed
- The effects of HIV/AIDS intervention groups for high-risk women in urban clinics.Am J Public Health · 1994206 citationsRCR 10.9
- Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C.Hepatology · 200880 citationsRCR 2.1
- Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease.Br J Clin Pharmacol · 201980 citationsRCR 4.4
- Trust, benefit, satisfaction, and burden: a randomized controlled trial to reduce cancer risk through African-American churches.J Gen Intern Med · 200362 citationsRCR 2.3
- Patterns of food and acid reflux in patients with low-grade oesophagitis--the role of an anti-reflux agent.Aliment Pharmacol Ther · 199830 citationsRCR 1.4
- Ganciclovir pharmacokinetic parameters do not change when extending valganciclovir cytomegalovirus prophylaxis from 100 to 200 days.Transplantation · 201023 citationsRCR 0.8
- A Phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage.J Neurosurg · 201619 citationsRCR 0.9
- Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitors.Clin Pharmacol Ther · 200317 citationsRCR 0.4
- 15 citationsRCR 1.5
- 14 citationsRCR 3.4